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The primary task of white adipose tissue (WAT) is the
storage of lipids. However, ‘‘beige’’ adipocytes also
exist inWAT. Beige adipocytes burn fat and dissipate
the energy as heat, but their abundance is diminished
in obesity. Stimulating beige adipocyte develop-
ment, or WAT browning, increases energy expendi-
ture and holds potential for combating metabolic
disease and obesity. Here, we report that insulin
and leptin act together on hypothalamic neurons to
promote WAT browning and weight loss. Deletion
of the phosphatases PTP1B and TCPTP enhanced
insulin and leptin signaling in proopiomelanocortin
neurons and prevented diet-induced obesity by
increasing WAT browning and energy expenditure.
The coinfusion of insulin plus leptin into the CNS or
the activation of proopiomelanocortin neurons also
increased WAT browning and decreased adiposity.
Our findings identify a homeostatic mechanism for
coordinating the status of energy stores, as relayed
by insulin and leptin, with the central control of
WAT browning.
INTRODUCTION
There are two types of adipose tissue in humans, white adipose
tissue (WAT) and brown adipose tissue (BAT). WAT can store
vast amounts of chemical energy as triglycerides (TAGs) for uti-
lization during periods of fasting or starvation. In contrast, BAT
dissipates the chemical energy stored in TAGs as heat to pre-
serve core temperature during hypothermia and to counteract
obesity (Rosen and Spiegelman, 2014). Brown adipocytes
contain a high density of mitochondria with high amounts of un-
coupling protein-1 (UCP-1) allowing for the uncoupling of fatty
acid oxidation from ATP production to generate heat (Rosen88 Cell 160, 88–104, January 15, 2015 ª2015 Elsevier Inc.and Spiegelman, 2014). Although BAT was initially considered
to be present only in infants, it is now established that substantial
depots of UCP-1 expressing brown-like fat can be detected in
the supraspinal, supraclavicular, pericardial, and neck regions
of adult humans (Cypess et al., 2009; van Marken Lichtenbelt
et al., 2009; Virtanen et al., 2009). These brown-like fat depots
can be induced in response to cold, but their abundance is
diminished in older and obese subjects (Lee et al., 2014; Ouellet
et al., 2011).
Brown-like fat is also found in rodents and is composed of
beige adipocytes interspersed among white adipocytes (Rosen
and Spiegelman, 2014). Under basal conditions, beige adipo-
cytes express little to no UCP-1, but UCP-1 induction in
response to cold promotes thermogenesis and energy expendi-
ture (Rosen and Spiegelman, 2014). Interestingly, the interscap-
ular BAT in human infants is similar to classical brown fat in
rodents (Lidell et al., 2013), whereas the brown-like fat in adult
humans has a molecular signature reminiscent of rodent beige
fat (Lidell et al., 2013; Wu et al., 2012). Increasing WAT browning
in rodents increases energy expenditure and suppresses diet-
induced obesity and glucose intolerance (Seale et al., 2011).
On the other hand, preventing WAT browning by deleting
Prdm16, a transcriptional cofactor that increases UCP-1 expres-
sion, promotes obesity and severe insulin resistance (Cohen
et al., 2014; Seale et al., 2011). Understanding themolecular pro-
cesses governingWAT browning is highly significant, as this may
identify novel approaches for increasing energy expenditure and
combating obesity and the metabolic syndrome. Efforts to date
have focused primarily on the role of factors that act directly on
beige preadipocytes, such as irisin and FGF21 (Bostro¨m et al.,
2012; Lee et al., 2014). However, there is mounting evidence
that the central nervous system (CNS) control of WAT browning
is also important (Plum et al., 2007; Ruan et al., 2014; Williams
et al., 2014).
Leptin is produced by adipocytes and is critical for energy
homeostasis and body weight control. Leptin receptors
(LEPRs) are expressed in distinct regions of the brain, including
the arcuate nucleus (ARC) of the hypothalamus (Myers et al.,
2008). The ARC contains two opposing neuronal populations:
the appetite-suppressing proopiomelanocortin (POMC) and
the orexigenic neuropeptide Y (NPY) and agouti-related peptide
(AgRP)-neuropeptide-expressing neurons (Cowley et al., 2001;
Elias et al., 1999). Leptin acts on POMC and NPY/AgRP
neurons to suppress food intake and promote energy expendi-
ture (Myers et al., 2008). One mechanism by which leptin
increases energy expenditure is through the promotion of
BAT thermogenesis. Leptin action in the hypothalamus in-
creases sympathetic nerve activity (SNA) to BAT, increasing
both UCP-1 expression and BAT activity (Commins et al.,
2000; Morrison et al., 2014). Leptin signals via the LEPR to
activate Janus-activated kinase (JAK)-2, which promotes
signaling via effector cascades, including the phosphatidyinosi-
tol 3-kinase (PI3K)/AKT and signal transducer and activator of
transcription (STAT)-3 pathways, to increase Pomc expression
and inhibit Agrp expression (Myers et al., 2008). The principal
role of the melanocortin system in body weight control is
underscored by the marked obesity in humans and rodents
with null mutations in the leptin, LEPR, or POMC genes (Coll
et al., 2004).
Another peripheral factor affecting the melanocortin system
is insulin (Varela and Horvath, 2012). Insulin is released
from pancreatic b cells following a rise in blood glucose
and acts via the insulin receptor (IR) tyrosine kinase and the
PI3K/AKT pathway in liver, muscle, and fat to lower blood
glucose levels (Saltiel and Kahn, 2001). Insulin also acts in
the ARC on POMC and AgRP/NPY neurons to regulate
whole-body glucose metabolism and elicit anorectic responses
(Benoit et al., 2002; Bru¨ning et al., 2000; Ko¨nner et al., 2007).
One prevailing view is that different POMC neurons exist
and that leptin and insulin may act on distinct POMC neuronal
subsets (Hill et al., 2010; Sohn et al., 2011; Williams et al.,
2010).
The protein tyrosine phosphatases PTP1B (PTPN1) and
TCPTP (PTPN2) regulate body weight and glucose homeosta-
sis (Tiganis, 2013). PTP1B dephosphorylates JAK2 to suppress
leptin signaling in hypothalamic neurons, including POMC
neurons (Banno et al., 2010; Bence et al., 2006; Tiganis,
2013), whereas TCPTP dephosphorylates STAT3 in the hypo-
thalamus (Loh et al., 2011). We have taken advantage of mice
lacking PTP1B, TCPTP, or both phosphatases in POMC neu-
rons to demonstrate that PTP1B and TCPTP selectively regu-
late leptin and insulin signaling to affect body weight, energy
expenditure, and peripheral glucose homeostasis. We report
that the combined inactivation of PTP1B and TCPTP and the
promotion of leptin and insulin signaling in POMC neurons in-
creases WAT browning and energy expenditure and prevents
the development of diet-induced obesity. Our findings identify
a mechanism in which POMC neurons integrate insulin and
leptin feedback to drive WAT browning and maintain energy
homeostasis.
RESULTS
Decreased Adiposity in POMC-TC Mice
Previous studies have established that PTP1B regulates leptin
signaling in POMC neurons (Banno et al., 2010), but the preciseneuronal populations in which TCPTP exerts its effects remain
unknown. Thus, we assessed TCPTP versus GFP expression
in the hypothalami of Pomc-GFP transgenic mice (Figures 1A
and S1A available online). TCPTP protein was detected in
28.3% ± 5.9% of all GFP-positive POMC neurons in the ARC
with colocalization predominating in the central-caudal ARC
(Figure 1B), where both LEPR- and IR-responsive POMC neu-
rons have been detected (Williams et al., 2010). No TCPTP stain-
ingwas detected in the rostral ARC (Figures 1B andS1B). TCPTP
colocalization with GFP-expressing POMC neurons was
confirmed by flow cytometry in papain-digested hypothalami
(Figure 1C). LEPR-responsive POMC neurons are also found in
the nucleus of the solitary tract (NTS) in the hindbrain. Although
TCPTP expression was evident in the NTS, the majority of
TCPTP staining did not colocalize with GFP-expressing POMC
neurons (Figure S1C).
Next, we examined the localization of PTP1B in POMC neu-
rons in the ARC and its coincidence with TCPTP (Figures 1D–
1F and S1A). PTP1B was detected in 74.8% ± 11.2% of all
GFP-positive POMC neurons in the ARC, with PTP1B/GFP co-
localization predominating in the central-caudal ARC (Figure 1E).
In contrast to TCPTP, PTP1B was also expressed in the rostral
ARC (Figure S1B). Moreover, PTP1B expression in the central-
caudal ARC was not restricted to medial POMC neurons, where
it largely coincided with TCPTP (Figure 1F) but was also found in
lateral POMC neurons, where TCPTP expression was not
evident (Figures 1B, 1E, and 1F). Also, TCPTP, but not PTP1B,
was expressed in a subset ofmedial-caudal POMCneurons (Fig-
ure 1F). Thus, TCPTP and PTP1B are found in both overlapping
and distinct POMC neuronal subsets in the ARC.
To determine whether TCPTP might function in the melano-
cortin pathway, we crossed Ptpn2fl/fl mice (Loh et al., 2011)
with Pomc-Cre transgenic mice to excise Ptpn2 (Pomc-Cre;
Ptpn2fl/fl: POMC-TC) in POMC-expressing neurons (Figures
S1D and S1E). We compared these mice to PTP1B POMC
neuronal cell-specific knockout mice (Pomc-Cre;Ptpn1fl/fl:
POMC-1B), generated as described previously (Banno et al.,
2010). To visualize POMC cell-specific Cre-mediated recombi-
nation, we crossed POMC-TC mice to Z/EG reporter mice that
express GFP after Cre-mediated recombination (Figure 1G).
Z/EG;POMC-TC mice expressed GFP in the ARC and this over-
lappedwith 92%of POMC-expressing cells (Figures 1G and 1H);
no GFP staining was evident in non-POMC cells. As reported for
POMC-1Bmice (Banno et al., 2010), no differences were evident
in the number of hypothalamic POMC neurons in POMC-TC
mice (Figure 1I). POMC is expressed in the ARC, as well as
the pituitary and the NTS in the hindbrain. In addition, ARC
POMC neurons project to the lateral reticular nucleus in the
brainstem. Consistent with this, the recombined Ptpn2 allele
(DPtpn2) in POMC-TC mice was evident in whole-brain, hypo-
thalamic, pituitary, and hindbrain DNA extracts, but not in liver
extracts (Figure S1D). As expected, differences in TCPTP protein
were not observed in the hypothalamic extracts of POMC-TC
versus control mice (Figure S1E) because POMC neurons
constitute only a small proportion of the total hypothalamic cell
population (Cowley et al., 2001).
Body weights were not altered in POMC-TC or POMC-1B
versus floxed controls (Figures 2A, 2B, and S2A). Nevertheless,Cell 160, 88–104, January 15, 2015 ª2015 Elsevier Inc. 89
Figure 1. TCPTP and PTP1B in POMC Neurons
(A) Immunostaining for TCPTP in GFP-positive ARC POMC neurons.
(B) Rostral-caudal immunostaining quantification of GFP- and TCPTP-expressing ARC cells.
(C) Papain-digested hypothalami of Pomc-GFP mice were analyzed by flow cytometry for GFP and TCPTP.
(D) Immunostaining for PTP1B in GFP-positive ARC POMC neurons.
(legend continued on next page)
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epididymal and subcutaneous fat pad weights were decreased
in POMC-TC mice and variably decreased in POMC-1B mice;
only epididymal fat was significantly decreased in POMC-1B
mice (Figures 2A and 2B). Dual-energy X-ray absorptiometry
(DEXA) revealed that whole-body adiposity was significantly
decreased in POMC-TC mice, but not in POMC-1B mice (Fig-
ures 2A and 2B). Neither bone mineral densities nor lean
masses were altered (Figures 2A and 2B), and body lengths
and liver weights were similar in both groups (Figures S2B
and S2C). Previous studies have established that PTP1B dele-
tion in the pituitary (Cga-Cre;Ptpn1lox/lox) does not impact on
body weight (Banno et al., 2010). Similarly, we found that
TCPTP deletion in the pituitary (Cga-Cre;Ptpn2lox/lox) did not
result in overt differences in body weight or adiposity (Figures
S2D–S2H). The differences in adiposity in POMC-TC and
POMC-1B mice could not be ascribed to alterations in food
intake, energy expenditure, or activity, and there were no differ-
ences in fuel utilization (assessed by respiratory exchange ratio,
RER) in either group (Figures S2I and S2J). These findings are
consistent with previous studies reporting that LEPR or IR de-
ficiencies in POMC neurons do not alter food intake or RER
(Balthasar et al., 2004; Berglund et al., 2012; Hill et al., 2010;
Ko¨nner et al., 2007).
PTP1B, but Not TCPTP, Regulates Leptin Sensitivity
The deletion of TCPTP or PTP1B in neural and glial cells by
Cre-LoxP recombination using the Nes-Cre transgene en-
hances leptin sensitivity and protects mice from diet-induced
obesity (DIO) (Loh et al., 2011). Accordingly, we assessed
whether the decreased adiposity in chow-fed POMC-TC and
POMC-1B mice might be ascribed to enhanced leptin sensi-
tivity. POMC-TC, POMC-1B, or floxed control mice were
administered leptin intraperitoneally (IP) for 3 days, and body
weights and overnight food intake were recorded. Surprisingly,
deletion of TCPTP in POMC neurons did not alter the leptin-
mediated attenuation of food intake or decrease in body weight
(Figures 2C and S2K), despite the fact that 86.5% ± 6.5% of
LEPR-positive ARC POMC neurons express TCPTP (Fig-
ure S1E). In addition, plasma leptin levels (Figure 2D), leptin-
induced STAT3 Y705 phosphorylation (p-STAT-3; Figures S2L
and S2M), and leptin-induced hypothalamic Pomc expression
(Figure 2G) were not altered by TCPTP deficiency, which is
consistent with unaltered leptin sensitivity. As reported previ-
ously (Banno et al., 2010), PTP1B deficiency enhanced the
leptin-mediated repression of body weight (Figure 2E) without
overt changes in food intake (Figure S2K), reduced fed plasma
leptin levels (Figure 2F), and significantly increased leptin-
induced hypothalamic p-STAT-3 and Pomc expression (Figures
2G, S2N, and S2O); as expected, there were no differences in
Agrp and Npy expression (Figure S2P). Thus, the reduced
adiposity in POMC-TC mice is independent of changes in leptin
sensitivity.(E) Rostral-caudal immunostaining quantification of GFP- and PTP1B-expressing
(F) Immunostaining for PTP1B and TCPTP in GFP-positive POMC neurons in the
(G–I) (G) Immunostaining and (H and I) quantification of ARCGFP and POMC coloc
Representative images of three or more experiments are shown. Data are means ±
repeats.TCPTP, but Not PTP1B, Regulates Insulin Signaling
PTP1B and TCPTP dephosphorylate the IR and attenuate insu-
lin signaling in the periphery (Tiganis, 2013). As the CNS effects
of leptin and insulin overlap, and hypothalamic IR activation
alters peripheral lipid and glucose metabolism (Marino et al.,
2011; Plum et al., 2006), we monitored the effects of
TCPTP versus PTP1B deficiency on hypothalamic insulin
signaling. First, we determined whether PTP1B versus TCPTP
deficiency in POMC neurons enhanced insulin-induced PI3K/
AKT signaling in the ARC by monitoring AKT Ser-473 phos-
phorylation (p-AKT) by immunohistochemistry. TCPTP, but
not PTP1B, deficiency enhanced p-AKT staining in the ARC
in response to insulin (Figures 2H–2J). In keeping with the
selective effects on p-AKT signaling, insulin-induced hypotha-
lamic Pomc expression was significantly enhanced in POMC-
TC, but not in POMC-1B mice (Figure 2K). To independently
assess TCPTP’s capacity to regulate insulin signaling in
POMC neurons, we also took advantage of a highly specific
TCPTP inhibitor, compound 8 (Zhang et al., 2009). This inhibitor
is highly selective for TCPTP over PTP1B and intracerebroven-
tricular (ICV) compound 8 administration enhances leptin
signaling and sensitivity in wild-type mice, but not neuronal
cell-specific TCPTP knockout mice (Loh et al., 2011). Com-
pound 8 or aCSF (artificial cerebrospinal fluid) vehicle control
were administered ICV into fasted C57BL/6 mice that were
subsequently injected with insulin and hypothalami extracted
for analysis by real-time PCR. Administration of compound 8
increased insulin-induced Pomc expression by 2.5-fold (Fig-
ure 2L). Taken together, these results demonstrate that TCPTP
attenuates insulin signaling in POMC neurons.
Decreased Adiposity and Increased Energy Expenditure
in DKO Mice
Our results indicate that PTP1B and TCPTP differentially
contribute to leptin and insulin signaling in POMC neurons.
Hence, we generated POMC-TC and POMC-1B double-
knockout (DKO) mice to examine whether the combined in-
crease in IR and LEPR signaling in POMC neurons affects
body weight and glucose metabolism. DKO mice had a modest
reduction in body weight at 10 weeks of age, but body length,
liver weight, lean mass, and bone density were unaltered (Fig-
ures 3A–3C). Differences in body weight could be explained
by reduced whole-body adiposity (Figures 3B and 3C). The
reduction in body weight and adiposity in DKO mice was
accompanied by increased dark-phase energy expenditure
without significant changes in ambulatory activity or RER or
changes in food intake or feeding efficiency (Figure 3D). Further-
more, leptin sensitivity, as assessed by the effects of leptin on
body weight (Figure 3E) or inferred by the reduced fed plasma
leptin levels, was improved in DKO mice (Figure 3F). This was
accompanied by increased leptin-induced hypothalamic Pomc
expression in DKO mice (Figure 3G). Finally, insulin-inducedARC cells.
ARC.
alization and the total number of ARC POMC neurons in Z/EG;POMC-TCmice.
SEM for the indicated number of mice (30 sections/mouse) or (C) experimental
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(legend on next page)
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hypothalamic Pomc expression was also increased in DKO
mice (Figure 3H). These results are consistent with combined
deficiencies in PTP1B and TCPTP promoting both central leptin
and insulin signaling in POMC neurons to attenuate body
weight/adiposity.
Increased BAT Thermogenesis and WAT Browning in
DKO Mice
As the decreased adiposity and increased energy expenditure in
chow-fed DKO mice could not be accounted for by changes in
food intake or ambulatory activity, we examined whether DKO
mice had elevated BAT thermogenesis and/or WAT browning.
Although interscapular BAT mass was not altered (Figure S3A),
Ucp-1 gene expression was increased by more than 3-fold in
DKO mice, which is consistent with increased BAT activity (Fig-
ure 4A); BAT Ucp-1 expression was not altered in POMC-TC or
POMC-1B mice (Figure 4A). Indeed, BAT thermogenesis, as as-
sessed with sensors implanted below interscapular BAT, was
increased during the light phase (when mice are less active) in
DKOmice, but not in POMC-TC or in POMC-1Bmice (Figure 4B).
On the other hand, core temperature was not different from con-
trols (Figure S3B), which is consistent with normal whole-body
thermoregulation.
To determine whether WAT browning was also elevated in
DKO mice, we measured Ucp-1 gene expression in epididymal,
inguinal, mesenteric, and infrarenal fat (Figure 4A). We found that
Ucp-1 expression was increased by 15- to 20-fold, specifically in
inguinal WAT in DKO mice; inguinal Ucp-1 expression was not
altered in POMC-TC or POMC-1B mice (Figure 4A). Elevated
Ucp-1 mRNA in the inguinal fat of DKO mice was accompanied
by increases in UCP-1 protein (Figures 4C and 4D). Inguinal fat in
DKO mice had a distinct histological (hematoxylin and eosin
[H&E] staining) morphology (Figure 4E), characterized by the
presence of small adipocyte clusters with a multilocular lipid
droplet morphology, a characteristic of brown fat (Rosen and
Spiegelman, 2014). WAT browning in DKO mice also was
accompanied by increased expression of Prdm16 and Cidea
(Figure 4F), which are found in brown and beige adipocytes,
and Tmem26 and Cd137 (Figure 4F), which are specific to beige
adipocytes (Wu et al., 2012). Previous studies have shown that
cold-induced WAT browning is associated by increased angio-
genesis (Xue et al., 2009). We found that angiogenesis, assessed
with the angiogenesis marker CD34, was significantly elevated in
inguinal WAT in DKO mice (Figures S3C and S3D). Together,
these results demonstrate that the combined deletion of
PTP1B and TCPTP in POMC neurons drives BAT thermogenesis
and WAT browning.Figure 2. TCPTP and PTP1B Regulate Insulin and Leptin Signaling
(A and B) Body and WAT weights and body composition in 10-week-old POMC-
(C and E) POMC-TC, POMC-1B, and lox/lox mice were administered leptin, and
(D and F) Fed plasma leptin levels in 8-week-old mice.
(G) Hypothalamic Pomc gene expression in mice injected IP saline or leptin (1 mg
(H–J) p-AKT immunostaining in mice injected IP saline or insulin (5 mU/g, 15 min
(K) Hypothalamic Pomc gene expression in mice injected IP saline or insulin (0.8
(L) Hypothalamic Pomc gene expression in C57BL/6 mice administered saline or i
compound 8, ICV). Results are means ± SEM and are representative of three inde
ANOVA.SNA-Dependent WAT Browning Decreases Adiposity
To determine whether the increasedWAT browning in DKOmice
might be associated with SNA resulting from the combined dele-
tion of PTP1B and TCPTP in POMC neurons, we assessed tyro-
sine hydroxylase (TH) expression in the inguinal fat of chow-fed
DKO versus control mice. TH is the rate-limiting enzyme in cate-
cholamine synthesis and is a marker of sympathetic innervation
and was elevated in the inguinal fat of DKO mice (Figures S3E
and S3F). Next, to determine whether the increased SNA was
responsible for the WAT browning, we asked whether sympa-
thetic denervation might attenuate WAT browning in DKO
mice. To this end, we injected the neurotoxin 6-hydroxydop-
amine (6-OHDA) unilaterally into the inguinal fat area of
10 week-old DKO mice and monitored for changes in browning
2 weeks later. Unilateral sympathetic denervation dramatically
reduced TH staining and attenuated WAT browning when
compared with the contralateral fat pad, as assessed by gross
morphology, the expression of browning genes (Ucp-1,
Prdm16, Cidea) and histology/UCP-1 immunohistochemistry
(Figures 5A–5C) without affecting BAT Ucp-1 expression (Fig-
ure 5D). Indeed, sympathetic denervation reverted the increased
inguinal WAT Ucp-1 levels in DKO mice to levels comparable to
floxed control mice (Figure 5E). These results indicate that WAT
browning in DKO mice is dependent on SNA, rather than
changes in metabolism or circulating factors associated with
the decreased adiposity.
Next, we sought to determine the extent to which the
increased SNA to inguinal fat and consequent browning may
contribute to the increased energy expenditure and decreased
adiposity in DKO mice. We first asked whether WAT browning
and/or BAT activity might precede the decreased body weight/
adiposity evident in DKO mice. Increased WAT browning was
evident as early as 4 weeks of age, prior to any differences in
body weight or adiposity (Figures 4C, 4E, 4F, and 4H). Moreover,
the increased WAT browning in 4-week-old mice preceded
changes in BAT activity, as assessed by the expression of
Ucp-1 (Figure 4G). To directly test thatWAT browning decreased
adiposity in DKO mice, we bilaterally denervated the inguinal fat
pads of chow-fed DKO mice using 6-OHDA and measured the
effect on adiposity and browning after 5 weeks. Strikingly, sym-
pathetic denervation in DKOmice (assessed by TH staining; Fig-
ure S3G) resulted in increased weight gain and adiposity (Figures
5F, 5G, and S4A). Importantly, the increased adiposity in dener-
vated DKO mice was accompanied by decreased WAT brown-
ing and a reduction in energy expenditure (Figures 5H and 5I),
without alterations in RER or ambulatory activity (Figure S4B).
Moreover, the increased weight gain occurred despite BATTC, POMC-1B, and lox/lox mice.
body weights were monitored.
/g, 2 hr).
).
5 mU/g, 2 hr).
nsulin (0.85mU/g, IP, 2 hr), followed by aCSF or TCPTP inhibitor (1.5 ml 0.2 nmol
pendent experiments; significance was determined using (C, E, G–L) two-way
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Figure 3. Decreased Adiposity and Increased Energy Expenditure in DKO Mice
(A–D) (A) Body weight and body length; (B) tissue weights; (C) body composition; and (D) oxygen consumption, energy expenditure, ambulatory activity, RER,
daily food intake, and feeding efficiency in 8- to 10-week-old DKO and Ptpn1fl/flPtpn2fl/fl mice.
(E) Mice were administered leptin and body weights recorded.
(F) Fed plasma leptin levels in 8-week-old mice.
(G andH) Hypothalamic gene expression in fastedmice injected with IP saline, (G) leptin (1 mg/g), or (H) insulin. Results aremeans ±SEMand are representative of
at least two independent experiments; significance was determined (D, E, G, and H) using two-way ANOVA.activity remaining elevated in DKO mice (Figure 5H). Taken
together, these results causally link the increased energy expen-
diture and decreased adiposity in DKOmice to the elevatedWAT
browning.
DKO Mice Are Resistant to DIO
To assess the impact of combined PTP1B and TCPTP defi-
ciencies in POMC neurons and increased WAT browning on94 Cell 160, 88–104, January 15, 2015 ª2015 Elsevier Inc.DIO, we administered a high-fat diet to POMC-TC, POMC-1B,
or DKO mice for 12 weeks and monitored the effects on body
weight and glucose metabolism (Figures 6, S5, S6, and S7).
DKO mice exhibited a significant reduction in weight gain and
a marked reduction in adiposity (Figures 6A–6C and S7A). By
contrast, no differences were observed in body weight,
adiposity, or energy expenditure in POMC-1B or POMC-TC
mice (Figures S5A–S5D and S6A–S6D). The decreased weight
(legend on next page)
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gain in DKOmice was not associated with any difference in body
length, lean mass, or bone density (Figures 6C and 6D), but liver
weights were significantly reduced and accompanied by a
marked reduction in steatosis (Figure 6E). The decreased
adiposity in high-fat-fed (HFF) DKO mice was accompanied by
unaltered food intake, but feeding efficiency was increased
(Figure 6F), which is consistent with improved energy utilization.
Moreover, HFF DKO mice exhibited increased oxygen con-
sumption and energy expenditure, increased ambulatory activ-
ity, and increased dark-phase RER (Figure 6F). In keeping with
the resistance to DIO, DKO mice had significantly greater leptin
sensitivity (Figure 6G). Moreover, DKO mice exhibited a signifi-
cant reduction in fasted blood glucose levels and a trend for
reduced fasted insulin levels and had improved insulin and
glucose tolerances (Figures 6H–6J, S7B, and S7C), consistent
with overall improved glucose homeostasis. By contrast, HFF
POMC-TC and POMC-1B single-mutant mice did not exhibit
any differences in glucose homeostasis and leptin sensitivity
(Figures S5E–S5I and S6E–S6I). These results demonstrate
that the combined deletion of PTP1B and TCPTP in POMC neu-
rons prevents the development of DIO and the associated insulin
resistance, glucose intolerance, and hepatosteatosis.
The decreased adiposity in HFF DKO mice was accompanied
by elevated BAT Ucp-1 expression and increased inguinal WAT
browning (Figures 6K–6M). To determine the extent to which the
increased WAT browning in DKO mice prevented DIO, we bilat-
erally denervated (6-OHDA) the inguinal fat of DKOmice that had
beenHFF for 3weeks andmeasured effects on adiposity, energy
expenditure, and glucose homeostasis after a further 5 weeks of
high-fat feeding (Figures 6N, 6O, and S7D–S7J). Bilaterally
denervating inguinal fat in HFF DKO mice increased weight
gain and adiposity (Figures 6N, S7D, and S7E). The increased
weight gain was associated with decreased energy expenditure
and RER but no alterations in ambulatory activity or food intake
(Figures 6O and S7F). Moreover, the increased weight gain in the
denervated HFFDKOmicewas accompanied by elevated fasted
blood glucose levels, glucose intolerance, insulin resistance, and
hepatosteatosis (Figures S7G–S7J). These results demonstrate
that the resistance to DIO in HFF DKO mice can be attributed
at least in part to increased WAT browning.
Insulin and Leptin Promote WAT Browning in DKO Mice
Our studies indicate thatmice lacking PTP1B or TCPTP in POMC
neurons exhibit enhanced leptin or insulin signaling, respec-
tively, and that their combined deficiency increasesWAT brown-
ing and energy expenditure to decrease adiposity. Although
these results are consistent with enhanced insulin and leptin
signaling driving WAT browning, they do not exclude the contri-
bution of other pathways. Moreover, they do not exclude the
possibility that the combined PTP1B and TCPTP deficiencyFigure 4. Increased Browning in DKO Mice
(A) Ucp-1 gene expression in BAT and WAT depots from 12-week-old POMC-1B
(B) Interscapular BAT temperature.
(C–E) Histology (H&E), immunoblotting and immunohistochemistry of inguinal WA
(F and G) IngWAT or BAT gene expression.
(H) Body weights in 4- and 12-week-old mice. Data are means ± SEM and are re
using (A) one-way or (F, G, and H) two-way ANOVA.
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and STAT-3 signaling, so that leptin signaling alone promotes
WAT browning. To test this, we administered POMC-1B (leptin
hypersensitive) or POMC-TC (insulin hypersensitive) mice either
vehicle or leptin and assessed the effects on body weight, WAT
browning, and BAT activity (Figures 7A and 7B). We reasoned
that, if both leptin and insulin signaling are required in POMC
neurons for WAT browning, then WAT browning would be great-
est in the leptin-treated POMC-TC mice, as POMC-TC mice are
insulin hypersensitive. On the other hand, if the exacerbation of
leptin signaling by combined PTP1B and TCPTP deficiencies
would be sufficient to drive browning, then this would be greatest
in POMC-1B mice that are leptin hypersensitive. POMC-TC,
POMC-1B, or floxed control mice were administered leptin on
a daily basis for 6 days, and body weights, WAT browning, and
BAT Ucp-1 expression were assessed. POMC-1B mice ex-
hibited the greatest decrease in body weight in response to
leptin (Figure 7A). Consistent with the previously established
potential for leptin to drive BAT thermogenesis, BAT Ucp-1
was elevated in leptin-treated control mice (as compared to
vehicle administered C57BL/6 mice), but this was not increased
further by PTP1B or TCPTP deficiency (Figure 7B). Leptin admin-
istration also modestly increased inguinal WAT browning (Fig-
ure 7B). However, browning was greatest for leptin-treated
POMC-TC mice (Figures 7B, 7C, S4C, and S4D). Thus, the
enhanced insulin and leptin signaling in POMC neurons may un-
derlie the WAT browning and consequently increased energy
expenditure and decreased adiposity in DKO mice.
Insulin and Leptin Act on ARC Neurons to Drive WAT
Browning
To directly assess the capacity of insulin and leptin to act syner-
gistically in the CNS to control WAT browning, we subcutane-
ously implanted osmotic minipumps to ICV administer either
vehicle, leptin, insulin, or leptin plus insulin into the lateral
ventricle over 6 days and monitored body weight, energy expen-
diture, BAT activity, and WAT browning (Figures 7D–7G and
S4E–S4H). We found that insulin infusion alone had no effect
on food intake or body weight (Figures 7D and S4F). This is in
keeping with previous studies demonstrating that the chronic
ICV administration of insulin does not alter food intake or overall
body weight (Koch et al., 2008). As expected, leptin decreased
body weight and adiposity, and notably, this was exacerbated
by the coinfusion of insulin (Figure 7D). Coinfusion of leptin and
insulin did not further reduce food intake compared to leptin-
only infusion (Figure S4F). To assess whether the synergistic
effects of insulin and leptin on body weight may result from
SNA-dependent WAT browning and/or BAT thermogenesis, we
measured the expression of thermogenic genes in BAT and
inguinal fat. We found (1) that BAT Ucp-1 expression increased, POMC-TC, DKO, and floxed control mice.
T (ingWAT).
presentative of three independent experiments; significance was determined
Figure 5. Denervation of DKO Inguinal WAT and Increases Body Weight
(A–D) IngWAT in 10-week-old DKOmice was unilaterally denervated (6-ODHA) and BAT and ingWAT extracted 2 weeks later for analysis. (A) Gross morphology,
(B) histology/immunohistochemistry, and (C and D) gene expression; sham vehicle-administered contralateral inguinal fat pads were used as controls.
(E) Contralateral sham versus denervated (6-ODHA) ingWAT from DKO versus Ptpn1fl/flPtpn2fl/fl mice analyzed for Ucp-1 expression.
(legend continued on next page)
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similarly in response to all treatments, but not by insulin alone
(Figure 7E) and (2) that leptin, but not insulin treatment alone,
resulted in a modest increase in the expression of browning
genes in inguinal fat (Figure 7E). In keeping with this, leptin alone
modestly increased TH and UCP-1 in inguinal fat and increased
whole-body energy expenditure (Figures 7F, 7G, and S4H).
However, the coinfusion of leptin and insulin resulted in amarked
increase in TH staining and WAT browning (Figures 7E, 7F, S4E,
S4G, and S4H). Moreover, the coinfusion of leptin plus insulin
resulted in a greater increase in energy expenditure than the infu-
sion of leptin alone (Figure 7G), which is consistent with the dif-
ference in energy expenditure being attributable to increased
WAT browning.
To determine the extent to which the leptin plus insulin-
induced increase in energy expenditure and weight loss may
be reliant on SNA-dependent WAT browning, we bilaterally
denervated (6-OHDA) the inguinal fat pads of mice that were
ICV infused with leptin plus insulin. We found that the increased
WAT browning (Ucp-1 expression) and energy expenditure and
decreased body weight resulting from the coinfusion of leptin
and insulin were significantly attenuated by the bilateral denerva-
tion of inguinal fat (Figures 7H–7J). However, the denervation did
not completely prevent the increase in energy expenditure and
decrease in body weight, probably because of the sustained
leptin-induced activation of BAT and the suppression of food
intake (Figures 7E, 7H, and 7J).
Next, we assessed whether the effects of the ICV-adminis-
tered insulin and leptin on WAT browning may be mediated via
neurons in the ARC. Moreover, because both insulin and leptin
can signal via PI3K to depolarize and activate POMC neurons
(Cowley et al., 2001; Hill et al., 2008; Qiu et al., 2010, 2014; Rah-
mouni et al., 2004), we determined whether the pharmacological
inhibition of PI3K could suppress WAT browning. Minipumps
and intra-ARC indwelling bilateral cannulas were used to infuse
vehicle, leptin plus insulin or leptin, or insulin plus the PI3K inhib-
itor LY294002 directly into the ARC over 6 days, and effects on
body weight and WAT browning were monitored (Figures 7K–
7M and S4I). The infusion of leptin/insulin directly into the ARC
decreased body weight and food intake and promoted WAT
browning, and these effects were attenuated by LY294002 (Fig-
ures 7K–7M and S4I). Taken together, these results demonstrate
that insulin and leptin act synergistically on cells in the ARC, at
least in part via PI3K, to increaseWAT browning and consequent
energy expenditure to decrease body weight.
ARC POMC Neurons Promote WAT Browning
We next sought to understand how leptin and insulin elicit syner-
gistic effects on ARC cells to promote WAT browning. Previous
studies have provided evidence for the existence of distinct
ARC POMC neurons that are differentially responsive to insulin
and leptin (Hill et al., 2010; Williams et al., 2010). To determine
whether insulin and leptin may promote browning by stimulating(F–H) 8-week-old Ptpn1fl/flPtpn2fl/fl and DKOmice were sham operated or bilatera
and (H) ingWAT and BAT Ucp-1 expression was measured.
(I) Energy expenditure and oxygen consumption in 24-week-old Ptpn1fl/flPtpn2fl/fl
means ±SEM and are representative of three independent experiments; significan
v/s Ptpn1fl/flPtpn2fl/fl; # denervated DKO versus sham-operated DKO.
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insulin plus leptin intraperitoneally and monitored for hypotha-
lamic STAT3 Y705 or AKT Ser-473 phosphorylation by immuno-
histochemistry (Figures S4J–S4L). Leptin stimulation resulted in
p-AKT and p-STAT-3 staining in both the ARC and DMH,
whereas insulin increased p-AKT largely in the ARC (Figure S4J).
Strikingly, insulin plus leptin stimulation resulted in p-AKT stain-
ing in ARC neurons that were devoid of p-STAT-3 (Figures S4J
and S4K). At least a subset of the cells staining for p-AKT only
also stained for POMC-derived a-MSH (Figure S4L). Thus,
insulin and leptin can stimulate distinct neurons in the ARC.
These results are consistent with the insulin plus leptin-mediated
promotion of WAT browning resulting from the increased
engagement of POMC neurons.
To assess whether the leptin/insulin synergy reflects the
increased recruitment of POMC neurons to the melanocortin
response, we sought to nonselectively activate ARC POMC neu-
rons with the stimulatory hM3Dq DREADD (designer receptors
exclusively activated by designer drugs) that is activated by
clozapine-N-oxide (CNO) (Krashes et al., 2011). rAAV-hM3Dq-
mCherry (capable of expressing hM3Dq-mCherry in a Cre-
dependent manner) was administered into the ARC of
10-week-old Pomc-Cre mice that were subsequently unilaterally
denervated (inguinal fat pads) with 6-OHDA. Mice were then
administered vehicle or CNO to depolarize POMC neurons,
and body weights and food intake were measured, and WAT
browning was assessed after 14 days. CNO decreased food
intake and bodyweight, which is consistent with POMCneuronal
activation (data not shown). Postmortem analysis confirmed
ARC targeting and mCherry expression in 73.1% ± 20.7% of
POMC neurons (Figures S4M and S4N). CNO administration
resulted in a marked increase in WAT browning in the sham-
operated contralateral inquinal fat pads, but not in the 6-OHDA
denervated inguinal fat pads (Figures 7N–7P). These results
demonstrate that the nonselective activation of ARC POMC neu-
rons promotes the SNA-dependent browning of inguinal WAT.
This is consistent with the synergistic actions of insulin and leptin
on WAT browning, reflecting the increased engagement and
activation of POMC neurons.
DISCUSSION
Our studies demonstrate that leptin and insulin act synergisti-
cally on hypothalamic POMCneurons to promoteWAT browning
and energy expenditure to decrease adiposity. We suggest that
the engagement of insulin- and leptin-responsive POMC neu-
rons might allow for a graded melanocortin response to regulate
fat stores. Leptin would elicit immediate effects on food intake,
ambulatory activity, and energy expenditure by promoting BAT
activity, whereas leptin and heightened postprandial insulin
would act synergistically over the longer term and engage a
greater proportion of POMC neurons to promote overt WATlly denervated; (F) body weights and (G) WAT and BAT weights were assessed;
and DKO mice 5 weeks after sham or bilateral ingWAT denervations. Data are
ce was determined using (E and F) two-way or (G–I) one-way ANOVA. (F) * DKO
(legend on next page)
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browning and increase energy expenditure to limit weight gain.
This may be a major factor contributing to the ‘‘diet-induced
thermogenesis’’ model of body weight control, as first described
by Rothwell and Stock in 1979, whose studies involved BAT
cellular expansion and differentiation in rodents eating a cafete-
ria diet (Rothwell and Stock, 1979).
We found that TCPTP was expressed in 30%–40% and
PTP1B was expressed in 70% of ARC POMC neurons and that
the two phosphatases differentially contributed to leptin and in-
sulin signaling. Previous studies have established that both
phosphatases can attenuate leptin and insulin signaling in varied
cell types and tissues (Tiganis, 2013). Indeed, PTP1B attenuates
insulin signaling in SF-1 neurons in the VMH (Chiappini et al.,
2014), whereas neuronal TCPTP deficiency promotes hypotha-
lamic leptin signaling in vivo (Loh et al., 2011). In this study, we
found that PTP1B deficiency enhanced leptin, but not insulin
signaling, and TCPTP-deficiency enhanced insulin, but not leptin
signaling in POMC neurons. To some degree, the differential
contributions of the phosphatases may be due to their segrega-
tion in distinct POMC neurons. Such segregation is in keeping
with the existence of distinct subsets of POMC neurons in the
ARC (Hill et al., 2010; Sohn et al., 2011; Williams et al., 2010).
However, despite a significant degree of segregation, PTP1B
and TCPTP were coexpressed in medial POMC neurons in the
central-caudal ARC, and TCPTP was expressed in the majority
of LEPR-expressing POMC neurons. Therefore, the impact of
PTP1B versus TCPTP deficiency on leptin versus insulin
signaling and that of their combined deficiencies onWAT brown-
ing and energy expenditure may also be partly ascribed to func-
tional redundancies.
Irrespective of the roles of PTP1B and TCPTP, our findings
demonstrate that both insulin and leptin are required for optimal
CNS-mediated WAT browning. First, leptin administration
modestly increased browning in floxed control and leptin hyper-
responsive POMC-1B mice, but overt WAT browning was only
evident in insulin hyperresponsive POMC-TCmice. Second, lep-
tin or insulin ICV infusion alone had little effect on browning,
whereas the coinfusion of insulin and leptin strikingly enhanced
browning. By contrast, BAT activity was enhanced by 2- to
3-fold in response to leptin, but not insulin, and was not
enhanced further by the coinfusion of leptin and insulin. Previous
studies have implicated ARC/POMC neurons and/or leptin-
induced PI3K signaling in BAT thermogenesis and WAT brown-
ing (Commins et al., 2000; Plum et al., 2007; Williams et al.,
2014). However, our studies provide direct evidence for POMC
neuronal activation promoting SNA-dependent WAT browning
and demonstrate that insulin and leptin can act synergisticallyFigure 6. DKO Mice Are Resistant to DIO
(A–F) 8-week-old Ptpn1fl/flPtpn2fl/fl, and DKO mice were HFF for 12 weeks, and (A
length, (E) liver weight and histology, (F) oxygen consumption, energy expenditure
(G–I) (G) 12 week HFFmice were administered leptin, and body weights were mon
HFF mice.
(J) Insulin and glucose tolerance tests in 12 week HFF mice.
(K–M) (K and L) BAT or ingWAT gene expression, (M) ingWAT histology, and imm
(N andO)Ptpn1fl/flPtpn2fl/fl and DKOmicewere HFF and either shamoperated or b
and (N) incremental body weights and (O) energy expenditure were measured. Re
of three independent experiments; significance was determined using (A, B, F, G,
operated; pound (#), DKO sham versus DKO denervated.
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achieved with leptin alone. Moreover, our studies provide evi-
dence for the differential central control of BAT activity versus
WAT browning and thus ascribe distinct physiological functions
to these thermogenic tissues.
The importance of beige adipocytes to body weight control is
underscored by studies overexpressing or deleting the brown
adipose tissue determination factor Prdm16 in fat (Cohen et al.,
2014; Seale et al., 2011). Consistent with the importance of
WAT browning for thermogenesis and energy expenditure, beige
adipocytes can increase their energy uptake similar to BAT in the
context of cold or b3-adenergic stimulation (Bartelt et al., 2011).
Also, the thermogenic capacity of mitochondria from the inguinal
fat of cold-acclimated mice is one third of that of interscapular
BAT (Shabalina et al., 2013). Our studies highlight the capacity
of CNS-mediated WAT browning to regulate body weight and
adiposity independently of BAT thermogenesis.
In humans, low brown and brown-like fat activity correlates
with aging, obesity and diminishing metabolic health (Ouellet
et al., 2011), but whether such decreases are causal or conse-
quential and the basis for the decline remain unclear. Our results
suggest that the diminishing brown-like fat may occur as a
consequence of ARC cellular insulin and leptin resistance.
Indeed, elevated hypothalamic PTP1B and TCPTP exacerbate
cellular leptin resistance and DIO in mice (Loh et al., 2011). How-
ever, it remains to be establishedwhether PTP1B and TCPTP are
elevated in POMC neurons and whether this, along with other
factors that promote cellular leptin/insulin resistance, such as
SOCS3 (Mori et al., 2004), contribute to the diminished brown-
like fat in obesity.
In summary, our findings define the complementary roles of
TCPTP and PTP1B in central insulin and leptin signaling in
POMC neurons and the synergistic central actions of insulin
and leptin in the promotion of WAT browning. Our results sug-
gest that browningmay be the outcome of an integratedmelano-
cortin response to peripheral factors that convey the status of
both current (as conveyed by leptin) and anticipated energy re-
serves (as conveyed by increases in insulin) and highlight the
potential for CNS-mediated WAT browning to regulate adiposity
and combat obesity.EXPERIMENTAL PROCEDURES
Mice
We maintained mice on a 12 hr light-dark cycle in a temperature-controlled
high barrier facility with free access to food and water. Mice were fed a
standard chow (4.6% fat) or a high-fat diet (23% fat; 45% of total energy) incremental body weight, (B) fat pad weight, (C) body composition, (D) body
, ambulatory activity, RER, food intake, and feeding efficiency were assessed.
itored. Fed and fasted (H) blood glucose and (I) plasma insulin levels in 12 week
unohistochemistry from 12 week HFF mice.
ilaterally denervated after 3weeks; high-fat feedingwas continued for 5 weeks;
sults are means ± SEM for the indicated number of mice and are representative
I, J, N, and O) two-way ANOVA. (N) Asterisk (*) indicates floxed v/s DKO sham
Figure 7. Leptin and Insulin Induce WAT Browning
(A–C) 8-week-old mice were administered leptin IP; (A) daily body weights were recorded; (B and C) ingWAT and BAT were extracted for (B) analysis of Ucp-1
gene expression, (C) histology, and immunohistochemistry; C57BL/6 mice were administered vehicle as a control.
(D–G) 8-week-old C57BL/6 mice were ICV infused with vehicle, insulin (3 mU/day), leptin (4.8 mg/day), or insulin plus leptin, and (D) body weights monitored.
(E and F) BAT and ingWAT were extracted for (E) gene expression analyses, (F) histology, and immunohistochemistry, and (G) energy expenditure was assessed.
(legend continued on next page)
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from fat; SF04-027; Specialty Feeds) as indicated. Experiments were
approved by the Monash University School of Biomedical Sciences Animal
Ethics Committee.
Immunohistochemistry
Immunohistochemistry to monitor for p-STAT3 and p-AKT in hypothalamic
neurons was performed as described previously (Loh et al., 2011), and staining
for TCPTP, PTP1B, eGFP, and POMC was performed as described in the
Extended Experimental Procedures. For inguinal WAT immunohistochemistry,
tissue was formalin-fixed and processed for UCP-1, CD34, or TH immunore-
activity as described in the Extended Experimental Procedures.
Metabolic Measurements
Insulin and glucose tolerance tests, leptin sensitivity, blood glucose, and
plasma insulin measurements were performed as described previously (Loh
et al., 2009). Activity, food intake, and energy expenditure were assessed us-
ing a Comprehensive Lab Animal Monitoring System (Columbus Instruments),
and body composition was assessed by DEXA (Lunar PIXImus2; GE
Healthcare).
Real-Time PCR
RNA was extracted using TRIzol reagent (Sigma), reverse transcribed, and
processed for quantitative (DDCt) real-time PCR using either TaqMan Gene
Expression Assays (Applied Biosystems) or SsoAdvanced Universal SYBR
Green Supermix (BioRad) as described in the Extended Experimental
Procedures.
BAT and Core Temperature Measurements
BAT and core temperatures and locomotor activity were measured as
described previously (Enriori et al., 2011). E-Mitters (Mini Mitter Company)
were implanted beneath the BAT pad between the scapulae or into the perito-
neal cavity.
Sympathetic Denervation
Mice received 20 microinjections of vehicle or 6-hydroxydopamine [6-OHDA
(Sigma); 1 ml per injection, 9 mg/ml in 0.15 M NaCl containing 1% (w/v) ascor-
bic acid] as described previously (Chao et al., 2011) throughout the right or
both inguinal fat pads.
Intracerebroventricular and Intra-ARC Infusions
For intracerebroventricular infusions, 8-week-old C57BL/6 mice were im-
planted with a sterile osmotic pump connector cannula (Alzet Brain Infusion
Kit 3, DURECT Corp) as described in the Extended Experimental Procedures.
For intra-ARC infusions, mice were implanted with a bilateral cannula (Plastics
One) 1.4 mm caudal of bregma, extending 5.7 mm below dura, connected to a
minipump (Alzet model 1002, DURECT Corp) via PEG tubing and a Y
connector. Mice received 6 day infusions of vehicle, leptin (4.8 mg/day, Pepro-
tech), human insulin (3 mU/day, Sigma), or leptin plus insulin. Body weights
and food intake were monitored, and tissues were extracted.
DREADD
10- to 12-week-old Pomc-Cre mice were sterotaxically injected with rAAV-
hSyn-DIO-hM3D(Gq)-mCherry bilaterally into the ARC (coordinates, bregma:(H–J) C57BL/6 mice were subjected to sham or ingWAT bilateral denervations (
ingWAT Ucp-1 expression, and (J) energy expenditure were monitored.
(K–M) C57BL/6 mice were implanted with bilateral intra-ARC cannulas and infuse
inhibitor (PI3Ki; LY294002, 5 mg/day). (K) Daily body weights were recorded (insert
gene expression, (M) histology, and UCP-1 immunohistochemistry.
(N–P) Pomc-Cre mice were bilaterally injected with rAAV-hSyn-DIO-hM3D(Gq)-
denervated, and the mice were administered vehicle or CNO (1.5 mg/kg/day, IP) a
(P) histology, and immunohistochemistry.
Data are means ± SEM and are representative of three independent experimen
repeated measures or (B, E, G, I, J, L, and O) one-way ANOVA. In (A), the pound (#
asterisk (*) corresponds to leptin(L) or L/insulin(I) versus vehicle (V), and the poun
corresponds to L/I, or L/I + PI3Ki versus V, and the pound (#) L/I versus L/I + PI3
102 Cell 160, 88–104, January 15, 2015 ª2015 Elsevier Inc.anterior-posterior, –1.40 mm; dorsal-ventral, –5.80 mm; lateral, +/–0.30 mm,
200 nl/side) as described previously (Krashes et al., 2011). Two weeks
after rAAV delivery, mice were unilaterally denervated with 6-OHDA. One
week postdenervation, mice received daily injections of vehicle or CNO
(1.5 mg/kg, IP, Sigma) for 14 days. Body weights and food intake were re-
corded. Mice were anaesthetized, tissues were extracted, and mice were
perfused with paraformaldehyde for immunohistochemical assessment.
Statistical Analysis
Unless otherwise indicated, statistical significance was determined by a
two-tailed paired Student’s t test. p values < 0.05 were considered significant;
* or # p < 0.05, ** or ## p < 0.01, and *** or ### p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.12.022.
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